Journey Medical Corporation are readying to release their Phase 3 clinical trial data for DFD-29, their delayed release 40mg minocycline treatment for rosacea. Targeted as a competitor to Galderma’s successful doxycycline based Oracea, the yet to be named DFD-29 is expected to release clinical data that will demonstrate superior treatment results. According to Journey Medical’s […]
Rosacea-LTD has been discussed on rosacea forums on the internet for a long time. If I recall correctly, one of the reasons I created rosacea-support in the first instance, back in 1998, was to get to hear what others thought of this product. If you allow me to quote myself, this is what I had […]
Galderma has announced that Epsolay has been approved by the FDA for treating rosacea. Epsolay is a proprietary cream formulation of benzoyl peroxide, 5%, designated for the treatment of inflammatory lesions of rosacea in adults. In July 2021 Galderma announced an exclusive 5 year deal to market Epsolay in the US. The creators of Epsolay […]
In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]
This account of a struggle with getting diagnosed and then dealing with ocular rosacea is worth a read. The struggle is ongoing and we wish you all the best Darelle. Ocular Rosacea Is A Real Thing, And It Sucks My struggle with ocular rosacea began 18 months ago, when I first noticed some discomfort with […]
